论文信息 - Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second-third line erlotinib. - 字舞流文

Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second-third line erlotinib.

E. Felip | S. Cedrés | P. Martínez | A. Prat | E. Pallisa | J. Andreu | J. Baselga | J. D. Del Campo | G. Sala | I. Quispe | S. Cedres